Boletín de AInvest
Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
On April 14, 2025,
Corp experienced a significant drop of 11.97% in pre-market trading, reflecting a notable decline in investor sentiment.Pasithea Therapeutics Corp has seen a 17.36% increase over the past five trading days, contributing to a 14.52% gain during the second quarter of 2025. This positive trend suggests that the company's recent performance has been favorable, despite the recent pre-market drop.
Pasithea Therapeutics Corp's market capitalization stands at $1.556 million, with a net income of -$13.905 million. The company's revenue growth and income growth metrics are not available, indicating a need for further financial transparency.

Titulares diarios de acciones y criptomonedas, gratis en tu bandeja de entrada
Comentarios
Aún no hay comentarios